366 related articles for article (PubMed ID: 31351476)
1. Systemic TLR2 tolerance enhances central nervous system remyelination.
Wasko NJ; Kulak MH; Paul D; Nicaise AM; Yeung ST; Nichols FC; Khanna KM; Crocker S; Pachter JS; Clark RB
J Neuroinflammation; 2019 Jul; 16(1):158. PubMed ID: 31351476
[TBL] [Abstract][Full Text] [Related]
2. Toll-Like Receptor 2-Mediated Glial Cell Activation in a Mouse Model of Cuprizone-Induced Demyelination.
Esser S; Göpfrich L; Bihler K; Kress E; Nyamoya S; Tauber SC; Clarner T; Stope MB; Pufe T; Kipp M; Brandenburg LO
Mol Neurobiol; 2018 Aug; 55(8):6237-6249. PubMed ID: 29288338
[TBL] [Abstract][Full Text] [Related]
3. MiR-146a promotes oligodendrocyte progenitor cell differentiation and enhances remyelination in a model of experimental autoimmune encephalomyelitis.
Zhang J; Zhang ZG; Lu M; Zhang Y; Shang X; Chopp M
Neurobiol Dis; 2019 May; 125():154-162. PubMed ID: 30707940
[TBL] [Abstract][Full Text] [Related]
4. rHIgM22 enhances remyelination in the brain of the cuprizone mouse model of demyelination.
Mullin AP; Cui C; Wang Y; Wang J; Troy E; Caggiano AO; Parry TJ; Colburn RW; Pavlopoulos E
Neurobiol Dis; 2017 Sep; 105():142-155. PubMed ID: 28576706
[TBL] [Abstract][Full Text] [Related]
5. Differential role of Dok1 and Dok2 in TLR2-induced inflammatory signaling in glia.
Downer EJ; Johnston DG; Lynch MA
Mol Cell Neurosci; 2013 Sep; 56():148-58. PubMed ID: 23659921
[TBL] [Abstract][Full Text] [Related]
6. The Anti-Aging Protein Klotho Enhances Remyelination Following Cuprizone-Induced Demyelination.
Zeldich E; Chen CD; Avila R; Medicetty S; Abraham CR
J Mol Neurosci; 2015 Oct; 57(2):185-96. PubMed ID: 26067431
[TBL] [Abstract][Full Text] [Related]
7. Thymosin beta4 promotes oligodendrogenesis in the demyelinating central nervous system.
Zhang J; Zhang ZG; Li Y; Lu M; Zhang Y; Elias SB; Chopp M
Neurobiol Dis; 2016 Apr; 88():85-95. PubMed ID: 26805386
[TBL] [Abstract][Full Text] [Related]
8. Specific Blockade of Bone Morphogenetic Protein-2/4 Induces Oligodendrogenesis and Remyelination in Demyelinating Disorders.
Mausner-Fainberg K; Benhamou M; Golan M; Kimelman NB; Danon U; Marom E; Karni A
Neurotherapeutics; 2021 Jul; 18(3):1798-1814. PubMed ID: 34159538
[TBL] [Abstract][Full Text] [Related]
9. Experimental Demyelination and Axonal Loss Are Reduced in MicroRNA-146a Deficient Mice.
Martin NA; Molnar V; Szilagyi GT; Elkjaer ML; Nawrocki A; Okarmus J; Wlodarczyk A; Thygesen EK; Palkovits M; Gallyas F; Larsen MR; Lassmann H; Benedikz E; Owens T; Svenningsen AF; Illes Z
Front Immunol; 2018; 9():490. PubMed ID: 29593734
[TBL] [Abstract][Full Text] [Related]
10. Brain region-specific enhancement of remyelination and prevention of demyelination by the CSF1R kinase inhibitor BLZ945.
Beckmann N; Giorgetti E; Neuhaus A; Zurbruegg S; Accart N; Smith P; Perdoux J; Perrot L; Nash M; Desrayaud S; Wipfli P; Frieauff W; Shimshek DR
Acta Neuropathol Commun; 2018 Feb; 6(1):9. PubMed ID: 29448957
[TBL] [Abstract][Full Text] [Related]
11. EBI2 is expressed in glial cells in multiple sclerosis lesions, and its knock-out modulates remyelination in the cuprizone model.
Klejbor I; Shimshek DR; Klimaszewska-Łata J; Velasco-Estevez M; Moryś J; Karaszewski B; Szutowicz A; Rutkowska A
Eur J Neurosci; 2021 Aug; 54(3):5173-5188. PubMed ID: 34145920
[TBL] [Abstract][Full Text] [Related]
12. Thyroid hormone alleviates demyelination induced by cuprizone through its role in remyelination during the remission period.
Zhang M; Zhan XL; Ma ZY; Chen XS; Cai QY; Yao ZX
Exp Biol Med (Maywood); 2015 Sep; 240(9):1183-96. PubMed ID: 25577802
[TBL] [Abstract][Full Text] [Related]
13. The Toll-like Receptor 2 (TLR2)-related Immunopathological Responses in the Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis.
Jafarzadeh A; Nemati M; Khorramdelazad H; Mirshafiey A
Iran J Allergy Asthma Immunol; 2019 Jun; 18(3):230-250. PubMed ID: 31522431
[TBL] [Abstract][Full Text] [Related]
14. The role of CNS TLR2 activation in mediating innate versus adaptive neuroinflammation.
Luz A; Fainstein N; Einstein O; Ben-Hur T
Exp Neurol; 2015 Nov; 273():234-42. PubMed ID: 26342755
[TBL] [Abstract][Full Text] [Related]
15. Microglial aryl hydrocarbon receptor enhances phagocytic function via SYK and promotes remyelination in the cuprizone mouse model of demyelination.
Wang Y; Sun J; Zhu K; Wang D; Zhao X; Zhang H; Wu S; Wang Y; Wang J
J Neuroinflammation; 2023 Mar; 20(1):83. PubMed ID: 36966295
[TBL] [Abstract][Full Text] [Related]
16. The TAM receptor TYRO3 is a critical regulator of myelin thickness in the central nervous system.
Blades F; Aprico A; Akkermann R; Ellis S; Binder MD; Kilpatrick TJ
Glia; 2018 Oct; 66(10):2209-2220. PubMed ID: 30208252
[TBL] [Abstract][Full Text] [Related]
17. Detrimental and protective action of microglial extracellular vesicles on myelin lesions: astrocyte involvement in remyelination failure.
Lombardi M; Parolisi R; Scaroni F; Bonfanti E; Gualerzi A; Gabrielli M; Kerlero de Rosbo N; Uccelli A; Giussani P; Viani P; Garlanda C; Abbracchio MP; Chaabane L; Buffo A; Fumagalli M; Verderio C
Acta Neuropathol; 2019 Dec; 138(6):987-1012. PubMed ID: 31363836
[TBL] [Abstract][Full Text] [Related]
18. Gene expression in oligodendrocytes during remyelination reveals cholesterol homeostasis as a therapeutic target in multiple sclerosis.
Voskuhl RR; Itoh N; Tassoni A; Matsukawa MA; Ren E; Tse V; Jang E; Suen TT; Itoh Y
Proc Natl Acad Sci U S A; 2019 May; 116(20):10130-10139. PubMed ID: 31040210
[TBL] [Abstract][Full Text] [Related]
19. Exosomes derived from bone marrow mesenchymal stromal cells promote remyelination and reduce neuroinflammation in the demyelinating central nervous system.
Zhang J; Buller BA; Zhang ZG; Zhang Y; Lu M; Rosene DL; Medalla M; Moore TL; Chopp M
Exp Neurol; 2022 Jan; 347():113895. PubMed ID: 34653510
[TBL] [Abstract][Full Text] [Related]
20. P2X4 receptor controls microglia activation and favors remyelination in autoimmune encephalitis.
Zabala A; Vazquez-Villoldo N; Rissiek B; Gejo J; Martin A; Palomino A; Perez-Samartín A; Pulagam KR; Lukowiak M; Capetillo-Zarate E; Llop J; Magnus T; Koch-Nolte F; Rassendren F; Matute C; Domercq M
EMBO Mol Med; 2018 Aug; 10(8):. PubMed ID: 29973381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
